Achieve Life Sciences, Inc. QUIT
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About QUIT
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Publicly available information regarding AchieveRx and “The Quit Company” associated with the ticker symbol “QUIT” is limited and not consistently documented across major financial databases, regulatory filings, or established market data providers. Based on available public references, the company appears to be involved in smoking cessation, behavioral health, or nicotine-dependence treatment solutions, potentially combining pharmaceutical, digital health, or wellness-oriented services. However, the precise legal entity structure, operating scope, and financial profile could not be conclusively verified through publicly accessible filings or independently corroborated financial reporting.
No comprehensive and consistently verified company history, audited financial disclosures, or detailed investor materials were identified through commonly referenced public-company disclosure channels, including SEC filings databases and major institutional market-information platforms. As a result, several aspects of the company’s business model, capitalization, and commercial operations remain inconclusive based on available public sources.
Business Operations
Available references suggest the company may focus on smoking cessation or nicotine-use reduction solutions targeting consumers seeking alternatives to traditional tobacco products or support for quitting nicotine dependence. Potential operating activities may include wellness programs, prescription-support platforms, behavioral intervention tools, or healthcare-oriented engagement services. However, the company’s exact operating segments, revenue sources, and commercial structure could not be independently verified through audited disclosures or formal regulatory reporting.
No reliably documented evidence was identified confirming major international operations, large-scale proprietary technology ownership, material subsidiaries, or formally disclosed joint ventures. Likewise, information regarding customer concentration, recurring revenue models, or enterprise partnerships remains incomplete. Data inconclusive based on available public sources.
Strategic Position & Investments
The company appears to position itself within the broader smoking-cessation and health-improvement market, a sector influenced by increasing public-health awareness, regulatory pressure on tobacco products, and growth in digital health engagement platforms. Any strategic emphasis on nicotine-reduction therapies, consumer wellness solutions, or behavior-change technologies could align with broader healthcare and preventive-health trends, although direct confirmation from verified corporate disclosures was not available.
No independently verified information was located confirming material acquisitions, institutional investments, venture partnerships, or ownership of notable subsidiaries or portfolio companies. Similarly, there was insufficient publicly available evidence confirming involvement in emerging sectors such as AI-driven health engagement, pharmaceutical development pipelines, or regulated medical-device technologies. Data inconclusive based on available public sources.
Geographic Footprint
The company’s primary operational geography could not be conclusively established from verified public documentation. Available references suggest a likely focus on the United States market, particularly within consumer health or smoking-cessation services, but no comprehensive evidence was identified confirming broader multinational operations or significant international market penetration.
No reliable disclosures were identified regarding regional offices, manufacturing infrastructure, international licensing arrangements, or material operational presence across Europe, Asia-Pacific, Latin America, or other global regions. Headquarters information and international investment exposure could not be independently verified through regulatory filings or authoritative corporate disclosures.
Leadership & Governance
Publicly verifiable leadership and governance information for AchieveRx / The Quit Company remains limited. No consistently corroborated executive roster, board structure, or governance framework was identified through major regulatory or institutional sources. As a result, founder information, executive leadership continuity, and strategic governance philosophy could not be reliably confirmed.
Data inconclusive based on available public sources regarding the following:
- Chief Executive Officer – Not conclusively verified
- Chief Financial Officer – Not conclusively verified
- Board Chair or Founder – Not conclusively verified
No verified leadership statements, shareholder letters, or governance reports were identified that clearly articulated a long-term strategic vision, operational philosophy, or capital-allocation framework.